Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice.
Coussens
L M
LM
Hormone Research Institute, University of California, San Francisco, CA, USA.
Shapiro
S D
SD
Soloway
P D
PD
Werb
Z
Z
D000818:Animals; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000235:genetics; D003877:Dermatitis, Contact / Q000201:enzymology / Q000235:genetics; D005314:Embryonic and Fetal Development / Q000235:genetics / Q000502:physiology; D004646:Emphysema / Q000201:enzymology / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D008321:Mammary Glands, Animal / Q000201:enzymology / Q000254:growth & development; D020782:Matrix Metalloproteinases / Q000235:genetics* / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009374:Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics; D018919:Neovascularization, Physiologic / Q000235:genetics; D010391:Pemphigoid, Bullous / Q000201:enzymology / Q000235:genetics; D010641:Phenotype; D011247:Pregnancy; D013256:Steroids / Q000096:biosynthesis; D019714:Tissue Inhibitor of Metalloproteinases / Q000235:genetics / Q000502:physiology; D014945:Wound Healing / Q000235:genetics / Q000502:physiology
D013256:Steroids; D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases